Sabra Health Care REIT Reports 20.8% Revenue Growth to $221.8 Million

Sabra Health Care REIT, Inc. reported a total revenue of $221.8 million for the three months ended March 31, 2026, marking a significant increase of 20.8% compared to $183.5 million in the same period of the previous year. The growth was primarily driven by a 51% rise in resident fees and services, which reached $116.7 million, up from $77.4 million. However, rental and related revenues slightly decreased to $95.1 million from $96.0 million, reflecting transitions of certain facilities to managed communities and disposals of properties. The company’s net income attributable to Sabra Health Care REIT, Inc. was $40.9 million, a marginal increase from $40.3 million year-over-year.

In terms of operational changes, Sabra made notable acquisitions during the quarter, acquiring three Senior Housing - Managed communities and one skilled nursing/transitional care facility for a total of $96.1 million. This acquisition strategy is part of the company's ongoing efforts to expand its portfolio, which now includes 361 real estate properties held for investment. The company also recognized $3.3 million in total revenues and $0.1 million in net income from these newly acquired facilities. Additionally, Sabra's investment in unconsolidated joint ventures increased to $116.5 million, reflecting a strategic focus on diversifying its investment portfolio.

The company’s total assets rose to $5.6 billion as of March 31, 2026, compared to $5.5 billion at the end of 2025. This increase was driven by higher real estate investments, which reached $4.7 billion, up from $4.7 billion previously. However, total liabilities also increased to $2.8 billion from $2.7 billion, primarily due to higher borrowings under the revolving credit facility. The company reported a cash and cash equivalents balance of $116.5 million, significantly up from $71.5 million at the end of the previous fiscal year, indicating improved liquidity.

Looking ahead, Sabra Health Care REIT, Inc. anticipates continued growth in its investment portfolio and revenue streams, supported by its strategic acquisitions and operational efficiencies. The company plans to leverage its liquidity, which includes $1.2 billion in available cash and credit, to fund future investments and capital expenditures. Additionally, the board of directors declared a quarterly cash dividend of $0.30 per share, reflecting the company's commitment to returning value to shareholders while maintaining a focus on long-term growth and stability in the healthcare real estate sector.